Multiplexed FRET-FLIM Profiling of Immune Checkpoint Interactions Predicts Response to Atezolizumab in…

Myeloid-Adaptive Response to Atezolizumab (MARTA): A Two-Gene CXCL13–CXCL8 Transcriptomic Biomarker Across Renal Cell and Urothelial Carcinoma
Mario Uccello
Current issues in molecular biology1 Oct 2026Peer-reviewedCC BYFull textOncologyEurope PMCDOAJ
Circulating and tumor microenvironment immunomarkers associate with immunotherapy efficacy in advanced bladder urothelial carcinoma: an exploratory multicenter study integrating genomic and immunophenotypic profiling
Sha Liu, Junjun Lu, Zhaojie Lyu +7
Immunotherapy9 Oct 2026Peer-reviewedLicence not statedFull textOncologyPMC
A tumor-responsive nanoplatform orchestrating multiplexed macrophage engagers and immune checkpoint blockade for triple-negative breast cancer immunotherapy
Bo Xiang, Tao Liu, Wei Wang +3
Frontiers in Pharmacology4 Nov 2026Peer-reviewedCC BY 4.0Pharmacology & toxicologyCrossref
Urinary DNA Methylation Profiling Identifies a Biologically Distinct Subgroup of Low-Grade Urothelial Carcinoma with High-Grade-Associated Features
Marc Andreu-Inglés, Alina-Iuliana Onoiu, Marc Grifoll-Escoda +6
International Journal of Molecular Sciences8 Oct 2026Peer-reviewedCC BY 4.0Full textSurgery & anaesthesiaCrossrefEurope PMC
Single-cell profiling uncovers a rare mesenchymal-like urothelial state associated with sarcomatoid bladder cancer.
Justine J Jacobi, Dongbo Xu, Kyle Wieczorek +9
Cell death & disease4 Aug 2026Peer-reviewedCC BYFull textOncologyEurope PMCPMC

Cite

BibTeX

@misc{camacho2026multiplexed,
  title = {{Multiplexed FRET-FLIM Profiling of Immune Checkpoint Interactions Predicts Response to Atezolizumab in Urothelial Carcinoma}},
  author = {L. Camacho and C. Cacho-Navas and J. Agüero and B. Batmunkh and J. M. Gracia and K. O Sullivan and M. Rementeria and J. Miles and J. Gumuzio and F. Aguirre and S. Martin Algarra and C. E. de Andrea and P. J. Parker and V. Calleja},
  howpublished = {medRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.01.26361904},
  url = {https://www.medrxiv.org/content/10.64898/2026.09.01.26361904v1},
}

RIS

TY  - UNPB
TI  - Multiplexed FRET-FLIM Profiling of Immune Checkpoint Interactions Predicts Response to Atezolizumab in Urothelial Carcinoma
AU  - L. Camacho
AU  - C. Cacho-Navas
AU  - J. Agüero
AU  - B. Batmunkh
AU  - J. M. Gracia
AU  - K. O Sullivan
AU  - M. Rementeria
AU  - J. Miles
AU  - J. Gumuzio
AU  - F. Aguirre
AU  - S. Martin Algarra
AU  - C. E. de Andrea
AU  - P. J. Parker
AU  - V. Calleja
PY  - 2026
DA  - 2026/09/01
PB  - medRxiv
DO  - 10.64898/2026.09.01.26361904
UR  - https://www.medrxiv.org/content/10.64898/2026.09.01.26361904v1
ER  -

Related

Cite